Li‐wen Ko

2.1k total citations
34 papers, 1.5k citations indexed

About

Li‐wen Ko is a scholar working on Physiology, Neurology and Molecular Biology. According to data from OpenAlex, Li‐wen Ko has authored 34 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 14 papers in Neurology and 12 papers in Molecular Biology. Recurrent topics in Li‐wen Ko's work include Alzheimer's disease research and treatments (22 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). Li‐wen Ko is often cited by papers focused on Alzheimer's disease research and treatments (22 papers), Parkinson's Disease Mechanisms and Treatments (12 papers) and Neuroscience and Neuropharmacology Research (7 papers). Li‐wen Ko collaborates with scholars based in United States, China and Taiwan. Li‐wen Ko's co-authors include Shu‐Hui Yen, Shu-Hui Yen, Parimala Nacharaju, Michael DeTure, Tania F. Gendron, Ágnes Kenessey, Tadanori Hamano, Colin Easson, Wen‐Lang Lin and Ciro Isidoro and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Brain Research and The FASEB Journal.

In The Last Decade

Li‐wen Ko

34 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Li‐wen Ko United States 21 907 593 488 354 222 34 1.5k
Jerry P. Melchor United States 17 908 1.0× 634 1.1× 215 0.4× 311 0.9× 297 1.3× 22 1.7k
Rachel M. Bailey United States 18 575 0.6× 1.0k 1.7× 663 1.4× 333 0.9× 207 0.9× 29 1.9k
Takao Makifuchi Japan 21 611 0.7× 929 1.6× 554 1.1× 613 1.7× 291 1.3× 55 1.8k
Maria Damiano United States 14 249 0.3× 892 1.5× 544 1.1× 464 1.3× 175 0.8× 18 1.4k
Maxime W.C. Rousseaux United States 19 302 0.3× 913 1.5× 587 1.2× 404 1.1× 193 0.9× 39 1.7k
C. Ceuterick Belgium 27 584 0.6× 1.1k 1.8× 435 0.9× 935 2.6× 444 2.0× 58 2.1k
Anne Rovelet‐Lecrux France 20 1.2k 1.3× 804 1.4× 540 1.1× 288 0.8× 367 1.7× 38 2.1k
Rodrigo A. Fuentealba Chile 11 404 0.4× 801 1.4× 299 0.6× 336 0.9× 135 0.6× 14 1.4k
Reinhard Prior Germany 18 1.0k 1.1× 808 1.4× 214 0.4× 448 1.3× 254 1.1× 27 1.7k
An Snellinx Belgium 16 776 0.9× 1.1k 1.9× 320 0.7× 465 1.3× 298 1.3× 24 2.0k

Countries citing papers authored by Li‐wen Ko

Since Specialization
Citations

This map shows the geographic impact of Li‐wen Ko's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Li‐wen Ko with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Li‐wen Ko more than expected).

Fields of papers citing papers by Li‐wen Ko

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Li‐wen Ko. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Li‐wen Ko. The network helps show where Li‐wen Ko may publish in the future.

Co-authorship network of co-authors of Li‐wen Ko

This figure shows the co-authorship network connecting the top 25 collaborators of Li‐wen Ko. A scholar is included among the top collaborators of Li‐wen Ko based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Li‐wen Ko. Li‐wen Ko is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hamano, Tadanori, Shu-Hui Yen, Tania F. Gendron, Li‐wen Ko, & Masaru Kuriyama. (2011). Pitavastatin decreases tau levels via the inactivation of Rho/ROCK. Neurobiology of Aging. 33(10). 2306–2320. 42 indexed citations
2.
Zhang, Yong‐Jie, Tania F. Gendron, Ya-Fei Xu, et al.. (2010). Phosphorylation regulates proteasomal-mediated degradation and solubility of TAR DNA binding protein-43 C-terminal fragments. Molecular Neurodegeneration. 5(1). 33–33. 104 indexed citations
3.
4.
Ko, Li‐wen, et al.. (2008). Aggregates Assembled From Overexpression of Wild-Type α-Synuclein are not Toxic to Human Neuronal Cells. Journal of Neuropathology & Experimental Neurology. 67(11). 1084–1096. 38 indexed citations
5.
Ko, Li‐wen, et al.. (2008). Proteomic profiling of phosphoproteins and glycoproteins responsive to wild-type alpha-synuclein accumulation and aggregation. Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics. 1794(2). 211–224. 9 indexed citations
6.
Ko, Li‐wen, et al.. (2006). Cytosine β-D-arabinofuranoside used as a Paradigm Modifier to Increase Production of Tau Aggregates in a Cellular Model of Tauopathy. Neurochemical Research. 32(4-5). 823–832. 2 indexed citations
7.
Ko, Li‐wen, et al.. (2004). Recent advances in experimental modeling of the assembly of tau filaments. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1739(2-3). 125–139. 16 indexed citations
8.
Ko, Li‐wen, et al.. (2002). Cellular Models for Tau Filament Assembly. Journal of Molecular Neuroscience. 19(3). 309–316. 13 indexed citations
9.
DeTure, Michael, Li‐wen Ko, Colin Easson, & Shu-Hui Yen. (2002). tau Assembly in Inducible Transfectants Expressing Wild-Type or FTDP-17 tau. American Journal Of Pathology. 161(5). 1711–1722. 59 indexed citations
10.
DeTure, Michael, Li‐wen Ko, S. -H. Yen, et al.. (2000). Missense tau mutations identified in FTDP-17 have a small effect on tau–microtubule interactions. Brain Research. 853(1). 5–14. 69 indexed citations
11.
Ko, Li‐wen, Nitin D. Mehta, Matthew J. Farrer, et al.. (2000). Sensitization of Neuronal Cells to Oxidative Stress with Mutated Human α‐Synuclein. Journal of Neurochemistry. 75(6). 2546–2554. 74 indexed citations
12.
Yen, Shu‐Hui, Michael Hutton, Michael DeTure, Li‐wen Ko, & Parimala Nacharaju. (1999). Fibrillogenesis of Tau: Insights from Tau Missense Mutations in FTDP‐17. Brain Pathology. 9(4). 695–705. 36 indexed citations
13.
Ko, Li‐wen, et al.. (1999). An immunochemical study on tau glycation in paired helical filaments. Brain Research. 830(2). 301–313. 57 indexed citations
14.
Ko, Li‐wen, Toshinari Odawara, & Shu-Hui Yen. (1997). Menadione-induced tau dephosphorylation in cultured human neuroblastoma cells. Brain Research. 760(1-2). 118–128. 24 indexed citations
15.
Ko, Li‐wen, et al.. (1996). Modulated induction of tau proteins in cultured human neuroblastoma cells. Brain Research. 707(2). 256–265. 7 indexed citations
16.
Dickson, Dennis W., S. Sinicropi, Shu‐Hui Yen, et al.. (1996). Glycation and microglial reaction in lesions of Alzheimer's disease. Neurobiology of Aging. 17(5). 733–743. 67 indexed citations
17.
Blass, John P., William R. Markesbery, Li‐wen Ko, et al.. (1994). Presence of neuronal proteins in serially cultured cells from autopsy human brain. Journal of the Neurological Sciences. 121(2). 132–138. 12 indexed citations
18.
Sheu, Kwan‐Fu Rex, Paul Szabo, Li‐wen Ko, & Lois M. Hinman. (1989). Abnormalities of Pyruvate Dehydrogenase Complex in Brain Diseasea. Annals of the New York Academy of Sciences. 573(1). 378–391. 2 indexed citations
19.
Hong, Show‐Jen, Li‐wen Ko, ­Low‐Tone Ho, & Jim C. Fong. (1988). Somatostatin modulation of neurally mediated pepsinogen secretion from frog esophageal mucosa. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 968(3). 401–407. 4 indexed citations
20.
Ko, Li‐wen. (1979). Cell biology studies on established glioma cell lines and clones in vitro /. OhioLink ETD Center (Ohio Library and Information Network). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jerry P. Melchor Breakdown of academic impact, for papers by Rachel M. Bailey Breakdown of academic impact, for papers by Takao Makifuchi Breakdown of academic impact, for papers by Maria Damiano Breakdown of academic impact, for papers by Maxime W.C. Rousseaux Breakdown of academic impact, for papers by C. Ceuterick Breakdown of academic impact, for papers by Anne Rovelet‐Lecrux Breakdown of academic impact, for papers by Rodrigo A. Fuentealba Breakdown of academic impact, for papers by Reinhard Prior Breakdown of academic impact, for papers by An Snellinx
Rankless by CCL
2026